Variant report
Variant | nsv968032 |
---|---|
Chromosome Location | chr4:21749872-21753493 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs561631342 | chr4:21749888-21749889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs150933105 | chr4:21749915-21749916 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs564929515 | chr4:21750004-21750005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs527305380 | chr4:21750024-21750025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs540698606 | chr4:21750043-21750044 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs184868375 | chr4:21750076-21750077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs140757963 | chr4:21750102-21750103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs532225654 | chr4:21750110-21750111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs560654750 | chr4:21750125-21750126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs145893070 | chr4:21750149-21750150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs17563769 | chr4:21750157-21750158 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs61007696 | chr4:21750160-21750161 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs368524172 | chr4:21750182-21750183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs570252958 | chr4:21750192-21750193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs566755491 | chr4:21750203-21750204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs533872293 | chr4:21750235-21750236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs190113033 | chr4:21750244-21750245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs576653423 | chr4:21750307-21750308 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs1841181 | chr4:21750371-21750372 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs541680810 | chr4:21750394-21750395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs138804815 | chr4:21750400-21750401 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs181580345 | chr4:21750446-21750447 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs543007923 | chr4:21750449-21750450 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs561169236 | chr4:21750451-21750452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs184537778 | chr4:21750499-21750500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs113620358 | chr4:21750544-21750545 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs540955459 | chr4:21750554-21750555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs565451738 | chr4:21750561-21750562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs532770886 | chr4:21750582-21750583 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs375054744 | chr4:21750716-21750717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs557084686 | chr4:21750727-21750728 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs550654530 | chr4:21750763-21750764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs562604900 | chr4:21750765-21750766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs552607299 | chr4:21750817-21750818 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs189521134 | chr4:21750834-21750835 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs114565427 | chr4:21750852-21750853 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs180773227 | chr4:21750866-21750867 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs116800895 | chr4:21750868-21750869 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs186187663 | chr4:21750876-21750877 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs566033812 | chr4:21750877-21750878 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs533811218 | chr4:21750888-21750889 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs17563824 | chr4:21750902-21750903 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs79891953 | chr4:21750958-21750959 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs1839526 | chr4:21750980-21750981 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs556133437 | chr4:21750982-21750983 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs575686993 | chr4:21750992-21750993 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs536383414 | chr4:21751027-21751028 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs189250165 | chr4:21751070-21751071 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs111746610 | chr4:21751099-21751100 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs115276470 | chr4:21751103-21751104 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17603634 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Neuroblastoma | 18923191 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Breast cancer | 17133270 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 22183965 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Cancer | 22183965 | CNVD |
Gastric cancer | 16891809 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:21737600-21754000 | Weak transcription | Fetal Heart | heart |
2 | chr4:21750800-21752200 | Enhancers | HMEC | breast |
3 | chr4:21751000-21752400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr4:21751200-21751400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr4:21751200-21751600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr4:21751200-21751600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
7 | chr4:21751200-21752200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr4:21751400-21751600 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
9 | chr4:21751400-21752200 | Enhancers | Brain Hippocampus Middle | brain |
10 | chr4:21751400-21752200 | Enhancers | Brain Inferior Temporal Lobe | brain |
11 | chr4:21751600-21754000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
12 | chr4:21751600-21755200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
13 | chr4:21752200-21754600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
14 | chr4:21752200-21764600 | Weak transcription | HMEC | breast |
15 | chr4:21752400-21755000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
16 | chr4:21753000-21754000 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
17 | chr4:21753200-21754800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
18 | chr4:21753200-21755200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
19 | chr4:21753400-21754200 | Enhancers | H1 Cell Line | embryonic stem cell |